Skip to main content

Latest SEC Filings — Page 20

Most recent SEC EDGAR filings across all covered tickers, sorted chronologically. Wiseek AI reads each filing and scores it 1–10 for market-moving potential; click through for full analysis.

Definitive Proxy Details Board Declassification, Special Meeting Rights, and Reveals Poor 2025 Executive Compensation Outcomes
Form DEF 14AGPK · Form DEF 14A · 6h ago
TRV filing
Form 144TRV · Form 144 · 6h ago
PTEN filing
Form 10-QPTEN · Form 10-Q · 6h ago
Elme Communities Details Over $27M in Executive Payouts Amidst Liquidation
ProForm 10-K/AELME · Form 10-K/A · 6h ago
NXT filing
Form 144NXT · Form 144 · 6h ago
Starbucks Reports Strong Q2 Results, Raises FY26 Guidance on Robust Sales & EPS Growth
ProForm 8-KSBUX · Form 8-K · 6h ago
Rogers Corp. Reports Strong Q1 2026 Results with Doubled Adjusted EPS and Positive Q2 Guidance
ProForm 8-KROG · Form 8-K · 6h ago
Welltower Reports Strong Q1 Results with 23% FFO Growth and Raises Full-Year Guidance
ProForm 8-KWELL · Form 8-K · 6h ago
Skycorp Solar Files $300M Universal Shelf Registration for Future Capital Raises
Form F-3PN · Form F-3 · 6h ago
Perceptive Capital Solutions Files S-4 for Merger with Freenome, Securing $240M PIPE Financing Amidst Significant Dilution
ProForm S-4PCSC · Form S-4 · 6h ago
LNKB filing
Form 4LNKB · Form 4 · 6h ago
Ouster Seeks Shareholder Approval to Double Authorized Common Stock, Enabling Significant Future Dilution
ProForm DEF 14AOUST · Form DEF 14A · 6h ago
Clearwater Paper Reports Q1 Loss, Announces Restructuring for $8-12M Annual Savings
Form 8-KCLW · Form 8-K · 6h ago
RGP filing
Form 8-KRGP · Form 8-K · 6h ago
Clover Health NEOs Miss 2025 Bonuses, Executive Chair Forfeits 12.7M PRSUs Amid Performance Shortfalls
ProForm DEF 14ACLOV · Form DEF 14A · 6h ago
EVCM filing
Form DEFA14AEVCM · Form DEFA14A · 6h ago
OPKO Health Reports Q1 2026 Results: Revenue Decline Offset by Improved Losses & Strong Pipeline Progress
Form 8-KOPK · Form 8-K · 6h ago
CX filing
Form 144CX · Form 144 · 6h ago
Ironwood Pharmaceuticals Discloses Adverse Opinion on Internal Controls, Seeks Approval for 10 Million Share Equity Plan Increase
ProForm DEF 14AIRWD · Form DEF 14A · 6h ago
Q1 Earnings Show Mixed Results, FFO Up Slightly, Company Authorizes $250M Share Repurchase Program
ProForm 10-QHIW · Form 10-Q · 6h ago
BOLT filing
Form DEFA14ABOLT · Form DEFA14A · 6h ago
Finwise Bancorp Proposes 5.5% Potential Share Dilution via Stock Plan Expansion
ProForm DEF 14AFINW · Form DEF 14A · 6h ago
Porch Group Reports Strong Q1 Results, Raises Full-Year Guidance on Insurance Services Growth
ProForm 8-KPRCH · Form 8-K · 6h ago
ALEC filing
Form DEFA14AALEC · Form DEFA14A · 6h ago
FDMT filing
Form DEFA14AFDMT · Form DEFA14A · 6h ago
Groupon Seeks Shareholder Approval for Officer Exculpation and Elects Directors at Annual Meeting
Form DEF 14AGRPN · Form DEF 14A · 6h ago
Bitfufu Reports Significant Net Loss, Unremediated Material Weakness in Internal Controls for 2025
ProForm 20-FFUFU · Form 20-F · 6h ago
Visa Authorizes New $20 Billion Share Repurchase Program Following Strong Q2 Earnings
ProForm 8-KV · Form 8-K · 6h ago
BGIN Blockchain Confirms 77.7% Revenue Plunge, $177M Net Loss for 2025 Amid Crypto Downturn and New Class Action Lawsuits
ProForm 20-FBGIN · Form 20-F · 6h ago
Onconetix Registers 25 Million Shares for Highly Dilutive ELOC Resale to Fund Operations and Merger
ProForm S-1ONCO · Form S-1 · 6h ago